With a first-in-class approval in China, Eli Lilly’s GLP-1 development engine has delivered yet again on the obesity front—although local biopharma outfit Innovent Biologics will be the one to ...

Please provide your email address to receive an email when new articles are posted on . An ACC panel states modern obesity medications may be considered as first-line therapy for treatment of ...

The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there's a genetic risk for the ...

Amgen's new drug MariTide shows promise in obesity treatment, with participants losing up to 16% body weight in a year with monthly shots.

Google’s new AI will help researchers understand how our genes work First came AlphaFold. Now comes AlphaGenome for DNA.

Eliminating Medi-Cal coverage for obesity medications undermines CA health care goals, increasing costs and harming low-income Californians.

Whatever else New York voters do, they must be sure to keep Zohran Mamdani far from City Hall — by leaving him out of their five picks on the ranked-choice voting ballot.

Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster treatment, an early-stage trial showed, as the drugmaker races to develop ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths worldwide, is extremely challenging to treat. However, the future of HCC ...

"This drug represents a completely new type of treatment and has the potential to be of great importance for patients with type 2 diabetes and obesity. Our substance appears to promote healthy ...

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people ...

NEWS 23 June 2025 Obesity drugs show promise for treating a new ailment: migraine Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.